Page last updated: 2024-08-24

1,2-dipalmitoyl-3-phosphatidylethanolamine and Metaplasia

1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Metaplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borchard, F; Hanisch, FG; Koldovsky, U1

Other Studies

1 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Metaplasia

ArticleYear
Monoclonal antibody 2B5 defines a truncated O-glycan, GlcNAc beta 1-3Gal beta 1-4GlcNAc beta 1-6 (GalNAc), on mucins from deep gastric and duodenal glands as well as metaplasia and neoplasia of gastric differentiation.
    Cancer research, 1993, Oct-15, Volume: 53, Issue:20

    Topics: Animals; Antibodies, Monoclonal; Carbohydrate Sequence; Cell Differentiation; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Duodenum; Enzyme-Linked Immunosorbent Assay; Gastric Juice; Gastric Mucosa; Glycolipids; Glycoproteins; Humans; Intestinal Mucosa; Metaplasia; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mucins; Oligosaccharides; Phosphatidylethanolamines; Stomach Neoplasms

1993